Arca
Skip to content
Tools
Tools

Duloxetine Delayed-Release Capsules

Recall D-0277-2025, part of FDA recall event 96427. See Rising Pharma Holdings's company page.

Rising Pharma Holding, Inc. started this Class II drug recall on Mar 5, 2025 (voluntary: firm initiated); FDA lists it as ongoing.

  • Classification: Class II
  • Started: Mar 5, 2025
  • Status: Ongoing

Why It Was Recalled

Class II

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.

Record

Product
Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC 57237-018-99
Quantity
1223 bottles
Lots and codes
Lot #: DTB23111A, Exp 8/31/2025
Distribution
Nationwide in the USA.
Recalling firm
Rising Pharma Holding, Inc., East Brunswick, NJ, United States
How the firm notified
Letter
FDA classified
Mar 14, 2025

Rising Pharma Holding, Inc.'s Other Recalls

Newest first, one product per recall event; search them all

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.